Briya, a healthtech AI company focused on evidence-driven discovery for life sciences and medical research, announced the appointment of Professor Jonathan M. Samet, MD, MS, as Chief Epidemiologist. In this role, Samet will lead the integration of epidemiological methodology into Briya’s AIRE research engine, reinforcing the company’s efforts to combine artificial intelligence with rigorous scientific research practices.
The appointment is designed to support Briya’s mission of transforming AI from a general-purpose technology into a research system capable of generating reliable and defensible evidence for medical and life sciences studies. By incorporating medical reasoning, study design principles, and endpoint validation directly into AI-driven workflows, the company aims to align its platform with established clinical research standards while addressing complex healthcare data and research challenges.
According to Briya, the expert-guided approach will help ensure that its platform remains grounded in core clinical research principles while enabling researchers and healthcare organizations to derive actionable insights from complex datasets.
Samet brings more than four decades of experience in clinical practice, epidemiology, and public health leadership. He currently serves as Professor of Epidemiology and Occupational and Environmental Health and previously served as Dean of the Colorado School of Public Health. During his career, he has also held leadership positions at the Johns Hopkins Bloomberg School of Public Health and the University of Southern California.
In addition, Samet is a member of the National Academy of Medicine and has chaired numerous committees for the organization. His leadership experience includes serving as president of the Society for Epidemiologic Research and chairing the U.S. Environmental Protection Agency’s Clean Air Scientific Advisory Committee. In 2025, he received the Calderone Prize in recognition of his contributions to public health.
Briya said its epidemiology-aware research capabilities will be demonstrated at HLTH Europe, where the company plans to showcase how its AI-powered platform can support clinical and biomedical research workflows.
The company’s AIRE platform is designed specifically for clinical and biomedical research applications. It assists researchers in collecting and analyzing clinical data, generating insights that can support cohort design, endpoint validation, and development milestones. Briya also emphasizes a federated data approach and full anonymization to maintain security, compliance, and trust while accelerating medical research and innovation.
KEY QUOTES:
“AI in healthcare doesn’t fail because it lacks the capability, it fails from a lack of trust and scientific rigor. Too often, these tools lack a true understanding of complex medical context, research methodology, and the transparency required to build that trust. With Prof. Samet joining Briya, we are reinforcing our commitment to building an AI ecosystem that researchers and clinicians can not only use but rely on for their critical work.”
David Lazerson, Co-founder and CEO, Briya
“As AI becomes ever more central to medical research, scientific validity and transparency must remain the uncompromising priority. Efficiency cannot come at the cost of accuracy. Because trust must be built in from the start, Briya is bringing exactly what the industry and researchers need. By embedding proven epidemiological methodology into its AI workflows, it ensures this powerful technology can be trusted and used for complex clinical and population health research.”
Professor Jonathan M. Samet, Chief Epidemiologist, Briya
